Judith Graham Pool Postdoctoral Research Fellowship in Hemophilia

Judith Graham Pool Postdoctoral Research Fellowship

Application Deadline: December 1
Award Start Date: July 1

The program is named for Dr. Judith Graham Pool. In 1965, Dr. Pool discovered a simple method of extracting the clotting factor from human plasma. This opened the door to a series of rapid developments that revolutionized the treatment of hemophilia including replacement therapy. Replacement therapy (i.e., the infusion of the missing clotting factor to prevent or stop bleeding) has made it possible for people with hemophilia to live relatively normal and productive lives and to avoid, in large measure, the potentially crippling effects of the disorder.

Only noncommercial institutions and investigators associated with a noncommercial institution are eligible for NHF funding.

All grant and fellowship applications are subjected to a rigorous peer review process. Applications are critiqued on scientific merit and relevance to NHF research priorities. Applications are reviewed and scored in terms of significance, approach, innovation, investigator, and environment. A panel selected by the Research Working Group, a volunteer group of scientific and lay leaders, reviews applications received. The NHF Medical and Scientific Advisory Council (MASAC) and the NHF Board of Directors grant final funding approval.

Eligibility
Applicants must have completed doctoral training and must enter the JGP fellowship program from a doctoral, postdoctoral, internship or residency training program. Established investigators or faculty members are not eligible. Applicants must be affiliated with domestic organizations such as universities, colleges, hospitals and laboratories. US citizenship is not required.

Permissible research topics include clinical or basic research on the biochemical, genetic, hematologic, orthopedic, psychiatric or dental aspects of the hemophilias or von Willebrand disease. Other topics include rehabilitation, therapeutic modalities, psychosocial issues, women's health issues, liver disease, or AIDS/HIV as they pertain to the hemophilias or von Willebrand disease.

It is expected that the fellow will spend at least 90% of the time on the research project for which funding is requested. The remaining 10% may be devoted to teaching or clinical work that is relevant to the research.

Funding
NHF awards up to two fellowships per year of $42,000, up to two years.

Inquiries
For further information, contact:

Neil Frick
Vice President for Research & Medical Information
National Hemophilia Foundation
116 W. 32nd Street, 11th Floor
New York, New York 10001
(800) 424-2634 ext. 3708 or (212) 328-3708
Fax: (212) 328-3799
E-mail: nfrick@hemophilia.org